Hympavzi
Marstacimab-hncq · Pfizer Laboratories Div Pfizer Inc
PRESCRIPTION ONLY (USA)Hympavzi ingredients
| Active ingredient | Strength |
|---|---|
| Marstacimab | 75 mg/.5mL, 150 mg/mL |
What Hympavzi is used for
Hympavzi is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Hympavzi
- Generic name
- Marstacimab-hncq
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA761369
- On the US market since
- 2024
Official information
- Hympavzi prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Marstacimab-hncq)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Hympavzi?
Hympavzi (Marstacimab-hncq) is a specialist medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Hympavzi?
Hympavzi contains Marstacimab (75 mg/.5mL, 150 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA